CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Option exercise Chief Medical Officer acquired 9,376 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Option exercise Director acquired 2,802 shares (option exercise)
- 4 Open-market buy Director bought 36,159 shares at $23.79 ($860,223)
- 4 Open-market buy Chief Clinical Dev. Officer bought 2,500 shares at $24.44 ($61,100)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $19.95 ($49,875)
- 4 Open-market buy Director bought 100,000 shares at $20.69 ($2,069,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Shares withheld for taxes President and CEO gave up 54,720 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 24,569 shares (to pay taxes)
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
Page 11 of 62 · 1,225 filings